In a patient taking evolocumab (Repatha), tezepelumab (Tezspire), estradiol and progesterone who presents with knee arthralgia and fever, generalized myalgia, abdominal cramps, brown‑yellow vaginal discharge, and malodorous urine, what is the appropriate evaluation and management?

Immediate Evaluation and Management

This patient requires urgent evaluation for septic arthritis and pelvic inflammatory disease (PID), with the brown-yellow malodorous discharge and knee fever (warmth/effusion) representing potentially serious infections that demand immediate diagnostic workup and empiric antibiotic therapy.

Critical Differential Diagnosis

The constellation of symptoms suggests two concurrent processes that require simultaneous evaluation:

1. Septic Arthritis (Knee)

• Knee "fever" (warmth) with joint pain is septic arthritis until proven otherwise
• Requires immediate arthrocentesis before antibiotics if feasible
• Send synovial fluid for:
  • Cell count with differential (>50,000 WBC suggests septic joint)
  • Gram stain and culture (including gonococcal culture on chocolate agar)
  • Crystal analysis to exclude gout/pseudogout

2. Pelvic Inflammatory Disease (PID) or Bacterial Vaginosis

• Brown-yellow malodorous vaginal discharge strongly suggests either:
  • Bacterial vaginosis (BV): Most common cause of malodorous discharge 1
  • Trichomoniasis: Can present with yellow-green malodorous discharge 2
  • PID: Especially concerning given systemic symptoms (myalgias, cramps)

Immediate Diagnostic Workup

Gynecologic Evaluation

Perform wet mount microscopy immediately 1:

• Mix vaginal discharge with saline on one slide, 10% KOH on second slide
• Whiff test: Fishy odor with KOH suggests BV or trichomoniasis 1
• Microscopy:
  • Look for clue cells (BV)
  • Look for motile trichomonads (trichomoniasis)
  • Check vaginal pH (>4.5 suggests BV or trichomoniasis) 1

Additional Testing

• Cervical cultures for N. gonorrhoeae and C. trachomatis 3
• Urinalysis and urine culture (malodorous urine suggests UTI)
• Blood cultures if febrile or systemically ill
• CBC with differential, ESR, CRP (inflammatory markers) 4
• Serum creatine kinase (CK) to evaluate for myositis 4

Empiric Treatment Strategy

If Septic Arthritis Suspected

Do not delay antibiotics if patient appears septic or joint aspiration unavailable:

• Empiric IV antibiotics covering Staph aureus and N. gonorrhoeae
• Consider vancomycin + ceftriaxone pending cultures

For Vaginal Discharge

If BV diagnosed (3 of 4 Amsel criteria: homogeneous discharge, clue cells, pH >4.5, positive whiff test) 1:

• Metronidazole 500 mg orally twice daily for 7 days 1
• Alternative: Metronidazole 2g single dose (lower cure rate: 84% vs 95%) 1
• Advise patient to avoid alcohol during treatment and for 24 hours after 1

If Trichomoniasis suspected (motile trichomonads on wet mount) 2, 5:

• Metronidazole 2g orally as single dose 5, 1
• Alternative: Metronidazole 500 mg twice daily for 7 days 1
• Treat sexual partners 5, 1

If PID suspected (cervical motion tenderness, adnexal tenderness, fever) 1:

• Requires broader antibiotic coverage per CDC PID guidelines
• Consider hospitalization if severely ill

For UTI

• Treat based on urinalysis/culture results with appropriate antibiotics

Medication-Related Considerations

Evolocumab (Repatha) Side Effects

While myalgias and arthralgias are reported with evolocumab 6, 7, they are typically:

• Mild and non-inflammatory (no fever, no joint effusion)
• Similar rates to placebo in clinical trials 6
• This presentation with knee fever is NOT consistent with evolocumab side effects

The FDA label for Repatha lists common adverse reactions as nasopharyngitis, upper respiratory infections, influenza, back pain, and injection site reactions—not septic arthritis or infectious symptoms 8.

Tezepelumab (Tezspire) Considerations

Immune checkpoint inhibitor-related arthritis can present with inflammatory joint symptoms 4, but:

• Tezepelumab is an anti-TSLP monoclonal antibody for asthma, not an immune checkpoint inhibitor
• The evidence provided about checkpoint inhibitor arthritis 4 is not applicable to this patient

Hormone Therapy

Estradiol and progesterone do not typically cause infectious symptoms or malodorous discharge.

Critical Next Steps

1. Urgent joint aspiration if septic arthritis suspected
2. Immediate wet mount and vaginal pH testing
3. Start empiric antibiotics if infection confirmed
4. Ensure adequate hydration (patient reports hydrating for cramps)
5. Test for other STDs including syphilis and HIV 3
6. Partner notification and treatment if STD diagnosed 5, 1

Common Pitfalls to Avoid

• Do not attribute infectious symptoms to medication side effects without ruling out infection first
• Do not delay arthrocentesis in suspected septic arthritis—this is a medical emergency
• Do not treat vaginal discharge empirically without proper diagnostic testing (wet mount, pH, whiff test)
• Do not forget to treat sexual partners if trichomoniasis or other STD diagnosed 5, 1
• Do not use metronidazole gel for trichomoniasis—only oral metronidazole is effective 1

The priority is ruling out life-threatening and function-threatening infections (septic arthritis, PID) before considering medication-related adverse effects.